This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Tohoku University, Biogen Ma Inc., Corxel Pharmaceuticals Hong Kong Limited. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2023-2026
Title: Kuniyasu Niizuma: Innovator in Medical Technology
Introduction
Kuniyasu Niizuma is a prominent inventor based in Sendai, Japan. He has made significant contributions to the field of medical technology, particularly in the treatment and prevention of cerebral hemorrhage. With a total of 4 patents to his name, Niizuma's work is recognized for its innovative approach to healthcare solutions.
Latest Patents
Niizuma's latest patents include a drug for treating or preventing cerebral hemorrhage, which features a compound represented by a specific formula or its pharmaceutically acceptable derivatives. Additionally, he has developed a blood flow field estimation apparatus that utilizes machine learning to analyze organ tissue three-dimensional structure data. This apparatus estimates the blood flow field in target organs, providing valuable insights for medical professionals.
Career Highlights
Throughout his career, Niizuma has worked with esteemed institutions such as Tohoku University and Biogen MA Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field, further enhancing his contributions to medical technology.
Collaborations
Some of his notable coworkers include Teiji Tominaga and Hitomi Anzai. Their collaborative efforts have played a crucial role in advancing the research and development of innovative medical solutions.
Conclusion
Kuniyasu Niizuma's work exemplifies the spirit of innovation in the medical field. His patents and collaborations reflect a commitment to improving healthcare through technology. His contributions are paving the way for future advancements in the treatment of cerebral hemorrhage and related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile